![Michele Washko](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michele Washko
Chief Executive Officer at Life Sciences Greenhouse of Central Pennsylvania
Profile
Michele Washko is President and CEO of LSG Investments.
She brings to LSG nearly 25 years’ experience in healthcare commercialization, finance and innovation.
She served as V.P., Strategic Services, for the Life Sciences Greenhouse from 2005 until 2015, when she departed for Geisinger Health System’s Institute for Advanced Application.
Ms. Washko went on to found Life Science Innovations, a boutique consulting firm, in 2017 and to serve as COO, then CEO, of Respana Therapeutics, Inc. Ms. Washko holds a Bachelor of Arts degree from Emory University, an MBA from Penn State University, and a certificate in Executive Leadership from M.I.T.
Michele Washko active positions
Companies | Position | Start |
---|---|---|
ProSanos Corp.
![]() ProSanos Corp. Medical/Nursing ServicesHealth Services ProSanos Corp. develops and provides healthcare solutions for the pharmaceutical and biotechnology industries. The company was founded by Jonathan A. Morris and Michael N. Liebman in 2000 and is headquartered in Harrisburg, PA. | Director/Board Member | 13/01/2010 |
Life Sciences Greenhouse of Central Pennsylvania
![]() Life Sciences Greenhouse of Central Pennsylvania Investment ManagersFinance Life Sciences Greenhouse of Central Pennsylvania (LSGPA) is a venture capital firm founded by Kevin M. Harter in 2002. The firm is headquartered in Harrisburg, Pennsylvania. | Chief Executive Officer | 01/04/2022 |
Former positions of Michele Washko
Companies | Position | End |
---|---|---|
Carbon Nanoprobes, Inc.
![]() Carbon Nanoprobes, Inc. Medical SpecialtiesHealth Technology Dubbed the photographers of nanotechnology, Carbon Nanoprobes, Inc. is making a name as experts in imaging the extremely small. CNP manufactures novel devices for high-end, high-resolution R&D and production imaging environments. These devices are made possible by using carbon nanotube probes for the atomic force microscope. CNP products include Superior metrology solutions for semiconductor manufacturing, Cost effective, efficient, high-resolution images for nanoscale research, and Fast and efficient high-resolution protein-imaging solutions for structural biology and drug discovery. The most exciting and cutting edge area of science today is taking place on the scale of only a few atoms. Nanotechnology promises advances in chip design, drug discovery and advanced materials. The ability to push the edge of nanotechnology necessarily relies upon tools and instruments that can touch, feel and see at the nanoscale. CNP is commercializing a device promising interaction with samples as small as a single molecule. CNProbes is committed to the mass fabrication of nanostructured Atomic Force Microscope (AFM) consumables. Its introduction of the first commercially viable carbon nanotube probe will provide industries from semiconductor and biopharmaceutical to corporate research and academia, an instrument capturing the ballooning demand for more accurate, high-resolution imaging solutions. With the advent of the mass-production of carbon nanotube tips, the company can multiply the power of the atomic force microscope to unprecedented levels. | Director/Board Member | 20/01/2011 |
Propel Carbon Nanoprobes, Inc. | Corporate Officer/Principal | - |
MERCK & CO., INC. | Corporate Officer/Principal | - |
Training of Michele Washko
Emory University | Undergraduate Degree |
Arcadia University | Graduate Degree |
The Pennsylvania State University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
MERCK & CO., INC. | Health Technology |
Private companies | 4 |
---|---|
Carbon Nanoprobes, Inc.
![]() Carbon Nanoprobes, Inc. Medical SpecialtiesHealth Technology Dubbed the photographers of nanotechnology, Carbon Nanoprobes, Inc. is making a name as experts in imaging the extremely small. CNP manufactures novel devices for high-end, high-resolution R&D and production imaging environments. These devices are made possible by using carbon nanotube probes for the atomic force microscope. CNP products include Superior metrology solutions for semiconductor manufacturing, Cost effective, efficient, high-resolution images for nanoscale research, and Fast and efficient high-resolution protein-imaging solutions for structural biology and drug discovery. The most exciting and cutting edge area of science today is taking place on the scale of only a few atoms. Nanotechnology promises advances in chip design, drug discovery and advanced materials. The ability to push the edge of nanotechnology necessarily relies upon tools and instruments that can touch, feel and see at the nanoscale. CNP is commercializing a device promising interaction with samples as small as a single molecule. CNProbes is committed to the mass fabrication of nanostructured Atomic Force Microscope (AFM) consumables. Its introduction of the first commercially viable carbon nanotube probe will provide industries from semiconductor and biopharmaceutical to corporate research and academia, an instrument capturing the ballooning demand for more accurate, high-resolution imaging solutions. With the advent of the mass-production of carbon nanotube tips, the company can multiply the power of the atomic force microscope to unprecedented levels. | Health Technology |
Life Sciences Greenhouse of Central Pennsylvania
![]() Life Sciences Greenhouse of Central Pennsylvania Investment ManagersFinance Life Sciences Greenhouse of Central Pennsylvania (LSGPA) is a venture capital firm founded by Kevin M. Harter in 2002. The firm is headquartered in Harrisburg, Pennsylvania. | Finance |
ProSanos Corp.
![]() ProSanos Corp. Medical/Nursing ServicesHealth Services ProSanos Corp. develops and provides healthcare solutions for the pharmaceutical and biotechnology industries. The company was founded by Jonathan A. Morris and Michael N. Liebman in 2000 and is headquartered in Harrisburg, PA. | Health Services |
Propel Carbon Nanoprobes, Inc. |
- Stock Market
- Insiders
- Michele Washko